Keywords
Hanseniasi
Epidemiology
Outliving
Epidemiology
Outliving
How to Cite
1.
MARLET JM, BELI A W. Esperanças de sobrevida na hanseníase. Hansen. Int. [Internet]. 1976 Nov. 30 [cited 2024 Nov. 23];1(2):191-20. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36042
Abstract
The outliving of 5,000 hanseniasis patients of the State of S. Paulo whose diagnosis had been made between 1947 and 1950, was calculated according to Chiang's method. The chances of outliving of the three clinical forms of hanseniasis (Virchovian, Tuberculoid and Indeterminate) were compared between them, as well as with the outliving of the Brazilian population in 1950. It is concluded that the I and V forms have similar chances of outliving, the T type coming in the third place.
References
1. BALTES, P.B. Longitudinal and crosssectional sequences in the study of age and generation effects. Hum.
Develop.; 11:146-171, 1968.
2. BELDA, W. Aspectos epidemiológicos da hanseníase no Estado de São Paulo em 1974. In CONGRESSO BRASILEIRO DE DERMATOLOGIA, 32°, Rio de Janeiro, 1975. Hansen. Int 1(1):11-24, 1976.
4. BERGER, A. Tábua de vida. New York, Columbia University, 1962. [Mimeografado]
5. CHIANG, L. C. Introduction to stochastic processes in biostatistics. New York, Wiley, 1968.
5. CHIANG, L. C. Stochastic study of the life table and its applications. Hum. Biol., 32:221-238, 1960.
6. COPELAND, B. E. et aL Long-term human reference values based on a specific age range. Report of five years experience. Z. Klin. Chem., 12:262-257, 1974.
7. DALLAS, J. Patient follow-up in a long-term study. Johns Hopk. Med. J., 128:244-251, 1971.
8. FLOOR, L. et aL Subject boss in a follow-up study. Mont. Retard., 10: 3-5, 1972.
9. MARLET, J. M. Estudo das probabilidades acumuladas de sobrevivência em pacientes hansenianos. São Paulo, 1975. [Tese-Faculdade de Medicina Universidade S. Paulo]
11. MERREL, M.; SCHULMAN, L. E.; BALTIMORE, M. D. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J. Chron. Die., 1:12-32, 1955.
12. SANTOS, S. F. L. Contribuição para o tratamento estocástico da tábua de sobrevivência e suas aplicações. São Paulo, 1974. [Tese-Faculdade de Saúde Pública da Universidade de São Paulo]
13. UNITED NATIONS. Methods for populations projections by sex and age. Populations studies, 25:70-81, 1956.
14. VILLAFANA, C. et at. The value of continued follow-up: a preventive medicine program. Indian Med. Surg,.
40:11-15, 1971.
Develop.; 11:146-171, 1968.
2. BELDA, W. Aspectos epidemiológicos da hanseníase no Estado de São Paulo em 1974. In CONGRESSO BRASILEIRO DE DERMATOLOGIA, 32°, Rio de Janeiro, 1975. Hansen. Int 1(1):11-24, 1976.
4. BERGER, A. Tábua de vida. New York, Columbia University, 1962. [Mimeografado]
5. CHIANG, L. C. Introduction to stochastic processes in biostatistics. New York, Wiley, 1968.
5. CHIANG, L. C. Stochastic study of the life table and its applications. Hum. Biol., 32:221-238, 1960.
6. COPELAND, B. E. et aL Long-term human reference values based on a specific age range. Report of five years experience. Z. Klin. Chem., 12:262-257, 1974.
7. DALLAS, J. Patient follow-up in a long-term study. Johns Hopk. Med. J., 128:244-251, 1971.
8. FLOOR, L. et aL Subject boss in a follow-up study. Mont. Retard., 10: 3-5, 1972.
9. MARLET, J. M. Estudo das probabilidades acumuladas de sobrevivência em pacientes hansenianos. São Paulo, 1975. [Tese-Faculdade de Medicina Universidade S. Paulo]
11. MERREL, M.; SCHULMAN, L. E.; BALTIMORE, M. D. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J. Chron. Die., 1:12-32, 1955.
12. SANTOS, S. F. L. Contribuição para o tratamento estocástico da tábua de sobrevivência e suas aplicações. São Paulo, 1974. [Tese-Faculdade de Saúde Pública da Universidade de São Paulo]
13. UNITED NATIONS. Methods for populations projections by sex and age. Populations studies, 25:70-81, 1956.
14. VILLAFANA, C. et at. The value of continued follow-up: a preventive medicine program. Indian Med. Surg,.
40:11-15, 1971.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
Download data is not yet available.
